Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Shenzhen Targetrx Biotechnology synthesizes Ret inhibitors

April 19, 2021

Medshine Discovery presents new BTK inhibitors

April 19, 2021

Beijing Jacobio Pharmaceuticals divulges new KRAS inhibitors

April 19, 2021

Phase I study of eryaspase in first-line pancreatic cancer escalates to next cohort

April 19, 2021

Phase III study of chiauranib in SCLC begins

April 19, 2021

Ideaya reports preliminary phase I/II data on darovasertib in metastatic uveal melanoma

April 16, 2021

Phase II trial of TQ-B3525 for advanced gynecological cancers begins enrollment

April 16, 2021

Discovery of allosteric MALT1 protease inhibitor JNJ-67856633 for cancer

April 16, 2021

JNJ-74856665 mediates potent antileukemic activity and differentiation in preclinical models

April 16, 2021

Nanjing TransThera Biosciences presents TAM family kinase inhibitors

April 16, 2021

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....